Hilary Cain MD

Associate Professor of Medicine (Pulmonary); Director of Clinical Activities, Pulmonary Section, VA CT Healthcare System, West Haven; Director, Medical Intensive Care Unit, VA CT Healthcare System, West Haven; Director, Pulmonary Function Laboratory, VA CT Healthcare System, West Haven

Departments & Organizations

Yale Medical Group

Office of Student ResearchInternal Medicine: Pulmonary, Critical Care & Sleep Medicine: Winchester Chest Clinic, Chronic Obstructive Pulmonary Disease (COPD) Center

Research Interests

Obstructive airways diseases; COPD; Asthma more...


  • M.D., New York Medical College, 1988

Selected Publications

  • Cain HC. Drug-induced Pulmonary Disease: Non-chemotherapeutic agents. Fishman's Pulmonary Diseases and Disorders. Chapter 59. Ed. Fishman A, et. al. 2007.
  • Kang MJ, Homer RJ, Gallo A, Lee CG, Crothers K, Cho SJ, Rochester C, Cain HC, Chupp G, Yoon HJ and Elias JA. IL-18 is induced and IL-18 receptor a plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. (accepted August 2006).
  • Friedman LN, Nash ER, Bryant J, Henry S, Shi J, D'Amato J, Khaled GH, Russi MB, O'Connor PG, Edberg SC, Pisani MA, Cain HC, Tanoue L, Weissman DN. High rate of negative tuberculin and QuantiFERON® tests in individuals with histories of past-positive skin tests. Infection Control Hosp. Epidemiol. Infect Control Hosp Epidemiol 2006 27:436-441.



Latest News


Edit Profile